Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Guanfacine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Guanfacine 2mg modified-release tablets
0404000V0AAADAD
|
Guanfacine | Guanfacine | Central Nervous System | 3,847 |
|
Guanfacine 1mg modified-release tablets
0404000V0AAACAC
|
Guanfacine | Guanfacine | Central Nervous System | 3,672 |
|
Guanfacine 3mg modified-release tablets
0404000V0AAAAAA
|
Guanfacine | Guanfacine | Central Nervous System | 3,304 |
|
Guanfacine 4mg modified-release tablets
0404000V0AAABAB
|
Guanfacine | Guanfacine | Central Nervous System | 2,754 |
|
Guanfacine 5mg modified-release tablets
0404000V0AAAEAE
|
Guanfacine | Guanfacine | Central Nervous System | No data available |
|
Guanfacine 6mg modified-release tablets
0404000V0AAAFAF
|
Guanfacine | Guanfacine | Central Nervous System | No data available |
|
Guanfacine 7mg modified-release tablets
0404000V0AAAGAG
|
Guanfacine | Guanfacine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.